October 16, 2023 — A door-to-balloon (D2B) time of 90-minutes or less is associated with improved outcomes for heart ...
October 16, 2023 — GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest ...
October 16, 2023 — Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, announced the first U.S ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 13, 2023 — Arineta Cardiac Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and ...
October 13, 2023 — InfoBionic, Inc. today announced that it received 510(k) clearance from the U.S. Food and Drug ...
October 13, 2023 — The newly MDR-certified Cardiomatics solution is accurate, fast and easy-to-use AI-based standalone ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 12, 2023 — Royal Philips, a global leader in health technology, and the World Stroke Organization (WSO), the ...
October 12, 2023 — Franklin Mountain Medical announced today that the Dib UltraNav Transseptal Catheter System, which ...
October 12, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
October 11, 2023 — Unvaccinated people who have recovered from COVID-19 are at heightened risk of heart complications ...
October 11, 2023 — Tenaya Therapeutics, Inc., a clinical-stage biotechnology company with a mission to discover, develop ...
October 11, 2023 — Realizing a vision to deliver the best care to patients close to where they live in northern Ohio, GE ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
October 11, 2023 — A newly-issued American Heart Association presidential advisory identifies the strong connections ...
October 11, 2023 — To gain the latest insight into genetic research for the treatment of hypertrophic cardiomyopathy ...
October 10, 2023 — Axon Therapies, a private company focused on addressing a root cause of heart failure, announced 6 ...